SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-24-005039
Filing Date
2024-09-04
Accepted
2024-09-03 17:32:20
Documents
2
Period of Report
2024-09-03

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k_090324.htm 6-K 4240
2 PRESS RELEASE exh_991.htm EX-99.1 7111
  Complete submission text file 0001171843-24-005039.txt   12401
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-40858 | Film No.: 241275196
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)